215 related articles for article (PubMed ID: 1666360)
1. Cross-resistance and cross-susceptibility between fluoroquinolone agents.
Barry AL; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1991 Dec; 10(12):1013-8. PubMed ID: 1666360
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
[TBL] [Abstract][Full Text] [Related]
3. Selection of a fluoroquinolone-class disk for susceptibility tests.
Barry AL; Fuchs PC
Am J Med; 1993 Mar; 94(3A):17S-22S. PubMed ID: 8383918
[TBL] [Abstract][Full Text] [Related]
4. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
Beskid G; Prosser BL
Am J Med; 1993 Mar; 94(3A):2S-8S. PubMed ID: 8383919
[TBL] [Abstract][Full Text] [Related]
5. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
Barry AL; Jones RN
J Antimicrob Chemother; 1989 Apr; 23(4):527-35. PubMed ID: 2745259
[TBL] [Abstract][Full Text] [Related]
6. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteria.
Cormican MG; Jones RN
J Antimicrob Chemother; 1995 Aug; 36(2):431-4. PubMed ID: 8522474
[TBL] [Abstract][Full Text] [Related]
8. Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
Barry AL; Fuchs PC
J Antimicrob Chemother; 1991 Nov; 28(5):695-9. PubMed ID: 1663929
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Mirelis B; Navarro F; MirĂ³ E; Coll R; Xicota MA; Prats G
Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
[TBL] [Abstract][Full Text] [Related]
11. Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).
Cormican MG; Marshall SA; Jones RN
Diagn Microbiol Infect Dis; 1995 Jan; 21(1):51-4. PubMed ID: 7789097
[TBL] [Abstract][Full Text] [Related]
12. Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.
Prosser BL; Beskid G
Diagn Microbiol Infect Dis; 1995 Jan; 21(1):33-45. PubMed ID: 7789095
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity evaluations of two new quinolones, PD127391 (CI-960 and AM-1091) and PD131628.
Barrett MS; Jones RN; Erwin ME; Johnson DM; Briggs BM
Diagn Microbiol Infect Dis; 1991; 14(5):389-401. PubMed ID: 1665774
[TBL] [Abstract][Full Text] [Related]
14. Detection of quinolone-resistant Neisseria gonorrhoeae.
Kam KM; Wong PW; Cheung MM; Ho NK
J Clin Microbiol; 1996 Jun; 34(6):1462-4. PubMed ID: 8735098
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of five quinolones against Chlamydia pneumoniae.
Hammerschlag MR; Hyman CL; Roblin PM
Antimicrob Agents Chemother; 1992 Mar; 36(3):682-3. PubMed ID: 1320366
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of CP-74667 compared with four other fluoroquinolones.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419
[TBL] [Abstract][Full Text] [Related]
17. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM
Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615
[TBL] [Abstract][Full Text] [Related]
18. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
19. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
Knapp JS; Hale JA; Neal SW; Wintersheid K; Rice RJ; Whittington WL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2442-5. PubMed ID: 8585723
[TBL] [Abstract][Full Text] [Related]
20. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
King A; Bethune L; Phillips I
J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]